Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Identification by high-throughput sequencing of HPV variants and quasispecies that are untypeable by linear reverse blotting assay in cervical specimens.

Molet L, Girlich D, Bonnin RA, Proust A, Bouligand J, Bachelerie F, Hantz S, Deback C.

Papillomavirus Res. 2019 Jul 5;8:100169. doi: 10.1016/j.pvr.2019.100169. [Epub ahead of print]

2.

Antiviral effects of Cacicol®, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infection.

Deback C, Rousseau A, Breckler M, Molet L, Boutolleau D, Burrel S, Roque-Afonso AM, Labetoulle M.

Antivir Ther. 2018;23(8):665-675. doi: 10.3851/IMP3254.

PMID:
30028308
3.

[The CXCL12/CXCR4 signaling pathway in the control of human papillomavirus infection: new susceptibility factors in viral pathogenesis].

Meuris F, Jaracz-Ros A, Gaudin F, Schlecht-Louf G, Deback C, Bachelerie F.

Med Sci (Paris). 2017 Aug-Sep;33(8-9):691-694. doi: 10.1051/medsci/20173308002. Epub 2017 Sep 18. French. No abstract available.

4.

Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.

Rousseau A, Boutolleau D, Titier K, Bourcier T, Chiquet C, Weber M, Colin J, Gueudry J, M'Garrech M, Bodaghi B, Burrel S, Agut H, Deback C; HEDGOF (Herpes Eye Disease Group of France), Labetoulle M.

Antiviral Res. 2017 Oct;146:205-212. doi: 10.1016/j.antiviral.2017.09.013. Epub 2017 Sep 20.

PMID:
28939476
5.

The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis.

Meuris F, Carthagena L, Jaracz-Ros A, Gaudin F, Cutolo P, Deback C, Xue Y, Thierry F, Doorbar J, Bachelerie F.

PLoS Pathog. 2016 Dec 5;12(12):e1006039. doi: 10.1371/journal.ppat.1006039. eCollection 2016 Dec.

6.

Mutation in the L3 Ribosomal Protein Could Be Associated with Risk of Selection of High-Level Linezolid-Resistant Staphylococcus epidermidis Strains.

Rouard C, Aslangul E, Rivière A, Deback C, Butel MJ, Doucet-Populaire F, Bourgeois-Nicolaos N.

Microb Drug Resist. 2017 Jun;23(4):462-467. doi: 10.1089/mdr.2016.0137. Epub 2016 Oct 18.

PMID:
27754824
7.

Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014.

Schuffenecker I, Mirand A, Josset L, Henquell C, Hecquet D, Pilorgé L, Petitjean-Lecherbonnier J, Manoha C, Legoff J, Deback C, Pillet S, Lepiller Q, Mansuy JM, Marque-Juillet S, Antona D, Peigue-Lafeuille H, Lina B.

Euro Surveill. 2016 May 12;21(19). doi: 10.2807/1560-7917.ES.2016.21.19.30226.

8.

Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.

Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, Peytavin G, Marcelin AG, Boué F, Balabanian K, Pourcher V; ANRS 154 LENAKAP trial group.

Br J Dermatol. 2016 Dec;175(6):1251-1262. doi: 10.1111/bjd.14748. Epub 2016 Oct 12.

PMID:
27177037
9.

Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.

Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S.

J Virol Methods. 2016 Jul;233:10-4. doi: 10.1016/j.jviromet.2016.03.006. Epub 2016 Mar 16.

PMID:
26994966
10.

Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature.

Deback C, Burrel S, Varnous S, Carcelain G, Conan F, Aït-Arkoub Z, Autran B, Gandjbakhch I, Agut H, Boutolleau D.

Antivir Ther. 2015;20(2):249-54. doi: 10.3851/IMP2818. Epub 2014 Jun 25. Review.

PMID:
25219330
11.

Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation.

Choquet S, Varnous S, Deback C, Golmard JL, Leblond V.

Am J Transplant. 2014 Apr;14(4):857-66. doi: 10.1111/ajt.12640. Epub 2014 Feb 19.

12.

Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipient.

Schnepf N, Dhédin N, Mercier-Delarue S, Andreoli A, Mamez AC, Ferry C, Deback C, Ribaud P, Robin M, Socié G, Simon F, Mazeron MC.

J Clin Virol. 2013 Dec;58(4):733-6. doi: 10.1016/j.jcv.2013.10.007. Epub 2013 Oct 16.

PMID:
24183928
13.

Molecular characterization of herpes simplex virus 2 strains by analysis of microsatellite polymorphism.

Burrel S, Ait-Arkoub Z, Voujon D, Deback C, Abrao EP, Agut H, Boutolleau D.

J Clin Microbiol. 2013 Nov;51(11):3616-23. doi: 10.1128/JCM.01714-13. Epub 2013 Aug 21.

14.

Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.

Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, Agut H, Gabison EE.

J Clin Virol. 2013 Sep;58(1):321-4. doi: 10.1016/j.jcv.2013.05.001. Epub 2013 May 31.

PMID:
23731845
15.

Clinical and microbiological evaluation of travel-associated respiratory tract infections in travelers returning from countries affected by pandemic A(H1N1) 2009 influenza.

Jauréguiberry S, Boutolleau D, Grandsire E, Kofman T, Deback C, Aït-Arkoub Z, Bricaire F, Agut H, Caumes E.

J Travel Med. 2012 Jan-Feb;19(1):22-7. doi: 10.1111/j.1708-8305.2011.00570.x. Epub 2011 Dec 8.

16.

Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.

Lascaux AS, Caumes E, Deback C, Melica G, Challine D, Agut H, Lévy Y.

J Med Virol. 2012 Feb;84(2):194-7. doi: 10.1002/jmv.23188.

PMID:
22170537
17.

Exhausted cytotoxic control of Epstein-Barr virus in human lupus.

Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, Boutolleau D, Parizot C, Dorgham K, Papagno L, Appay V, Amoura Z, Gorochov G.

PLoS Pathog. 2011 Oct;7(10):e1002328. doi: 10.1371/journal.ppat.1002328. Epub 2011 Oct 20.

18.

Rotavirus rearranged genomic RNA segments are preferentially packaged into viruses despite not conferring selective growth advantage to viruses.

Troupin C, Schnuriger A, Duponchel S, Deback C, Schnepf N, Dehee A, Garbarg-Chenon A.

PLoS One. 2011;6(5):e20080. doi: 10.1371/journal.pone.0020080. Epub 2011 May 17.

19.

Herpes simplex encephalitis : from virus to therapy.

Rozenberg F, Deback C, Agut H.

Infect Disord Drug Targets. 2011 Jun;11(3):235-50. Review.

PMID:
21488834
20.

Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients.

Arnaud L, Gorochov G, Charlotte F, Lvovschi V, Parizot C, Larsen M, Ghillani-Dalbin P, Hervier B, Kahn JE, Deback C, Musset L, Amoura Z, Haroche J.

Blood. 2011 Mar 10;117(10):2783-90. doi: 10.1182/blood-2010-10-313510. Epub 2011 Jan 4.

21.

Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.

Burrel S, Deback C, Agut H, Boutolleau D.

Antimicrob Agents Chemother. 2010 Nov;54(11):4833-42. doi: 10.1128/AAC.00669-10. Epub 2010 Aug 23.

22.

Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development.

Bonnafous P, Verbelen M, Petrella S, Deback C, Gautheret-Dejean A, Boutolleau D, Naesens L, Agut H.

Antiviral Res. 2010 Jun;86(3):316-9. doi: 10.1016/j.antiviral.2010.03.005. Epub 2010 Mar 16.

PMID:
20298721
23.

Microsatellite analysis of HSV-1 isolates: from oropharynx reactivation toward lung infection in patients undergoing mechanical ventilation.

Deback C, Luyt CE, Lespinats S, Depienne C, Boutolleau D, Chastre J, Agut H.

J Clin Virol. 2010 Apr;47(4):313-20. doi: 10.1016/j.jcv.2010.01.019. Epub 2010 Feb 20.

PMID:
20172760
24.

Detection of pandemic (H1N1) 2009 virus in patients treated with oseltamivir.

Boutolleau D, Houhou N, Deback C, Agut H, Brun-Vezinet F.

Emerg Infect Dis. 2010 Feb;16(2):351-2. doi: 10.3201/eid1602.091328. No abstract available.

25.

Testing the susceptibility of human herpesviruses to antivirals.

Agut H, Boutolleau D, Deback C, Bonnafous P, Gautheret-Dejean A.

Future Microbiol. 2009 Nov;4(9):1111-23. doi: 10.2217/fmb.09.83. Review.

PMID:
19895215
26.

[Evaluation of the LightCycler 480 real-time PCR system for the measurement of CMV, EBV, HHV-6 and BKV viral loads in whole blood].

Boutolleau D, Deback C, Géli J, Aït-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H.

Pathol Biol (Paris). 2010 Apr;58(2):166-9. doi: 10.1016/j.patbio.2009.06.006. Epub 2009 Nov 4. French.

PMID:
19892483
27.

Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factor.

Boutolleau D, Deback C, Bressollette-Bodin C, Conan F, Aït-Arkoub Z, Imbert-Marcille BM, Agut H.

Antivir Ther. 2009;14(6):847-52. doi: 10.3851/IMP1299.

PMID:
19812447
28.

Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: Evaluation on whole blood specimens and proficiency panels.

Deback C, Géli J, Aït-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H, Boutolleau D.

J Virol Methods. 2009 Aug;159(2):291-4. doi: 10.1016/j.jviromet.2009.03.027. Epub 2009 Apr 9.

PMID:
19490982
29.

Length variability of telomeric repeat sequences of human herpesvirus 6 DNA.

Achour A, Malet I, Deback C, Bonnafous P, Boutolleau D, Gautheret-Dejean A, Agut H.

J Virol Methods. 2009 Jul;159(1):127-30. doi: 10.1016/j.jviromet.2009.03.002. Epub 2009 Mar 14.

PMID:
19442857
30.

Epstein-Barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: a French national cross-sectional study.

Amiel C, Legoff J, Lescure FX, Coste-Burel M, Deback C, Fafi-Kremer S, Gueudin M, Lafon ME, Leruez-Ville M, Mengelle C, Payan C, Pillet S.

J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):427-9. doi: 10.1097/QAI.0b013e31819a22ec. No abstract available.

PMID:
19322036
31.

Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains.

Deback C, Boutolleau D, Depienne C, Luyt CE, Bonnafous P, Gautheret-Dejean A, Garrigue I, Agut H.

J Clin Microbiol. 2009 Mar;47(3):533-40. doi: 10.1128/JCM.01565-08. Epub 2008 Dec 24.

32.

Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection.

Boutolleau D, Deback C, Bressollette-Bodin C, Varnous S, Dhedin N, Barrou B, Vernant JP, Gandjbakhch I, Imbert-Marcille BM, Agut H.

Antiviral Res. 2009 Feb;81(2):174-9. doi: 10.1016/j.antiviral.2008.11.003. Epub 2008 Dec 6.

PMID:
19063923
33.

Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Sacre K, Nguyen S, Deback C, Carcelain G, Vernant JP, Leblond V, Autran B, Dhedin N.

J Virol. 2008 Oct;82(20):10143-52. doi: 10.1128/JVI.00688-08. Epub 2008 Aug 6.

34.

Detection of human herpesviruses HHV-6, HHV-7 and HHV-8 in whole blood by real-time PCR using the new CMV, HHV-6, 7, 8 R-gene kit.

Deback C, Agbalika F, Scieux C, Marcelin AG, Gautheret-Dejean A, Cherot J, Hermet L, Roger O, Agut H.

J Virol Methods. 2008 May;149(2):285-91. doi: 10.1016/j.jviromet.2008.01.026. Epub 2008 Mar 10.

PMID:
18329730
35.

Characterization of a cidofovir-resistant HHV-6 mutant obtained by in vitro selection.

Bonnafous P, Boutolleau D, Naesens L, Deback C, Gautheret-Dejean A, Agut H.

Antiviral Res. 2008 Mar;77(3):237-40. doi: 10.1016/j.antiviral.2007.12.004. Epub 2008 Jan 7.

PMID:
18241936
36.

Rearrangements of rotavirus genomic segment 11 are generated during acute infection of immunocompetent children and do not occur at random.

Schnepf N, Deback C, Dehee A, Gault E, Parez N, Garbarg-Chenon A.

J Virol. 2008 Apr;82(7):3689-96. doi: 10.1128/JVI.01770-07. Epub 2008 Jan 23.

37.

[Herpes simplex virus meningitis in 11 patients].

Binetruy C, Deback C, Roubaud-Baudron C, Agut H, Bricaire F, Bossi P.

Med Mal Infect. 2008 Mar;38(3):141-5. doi: 10.1016/j.medmal.2007.11.011. Epub 2008 Jan 10. French.

PMID:
18191515
38.

Monitoring of human cytomegalovirus infection in immunosuppressed patients using real-time PCR on whole blood.

Deback C, Fillet AM, Dhedin N, Barrou B, Varnous S, Najioullah F, Bricaire F, Agut H.

J Clin Virol. 2007 Nov;40(3):173-9. Epub 2007 Sep 29.

PMID:
17904901
39.

Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay.

Gouarin S, Vabret A, Scieux C, Agbalika F, Cherot J, Mengelle C, Deback C, Petitjean J, Dina J, Freymuth F.

J Virol Methods. 2007 Dec;146(1-2):147-54. Epub 2007 Jul 27.

PMID:
17673304
40.

Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.

Luyt CE, Combes A, Deback C, Aubriot-Lorton MH, Nieszkowska A, Trouillet JL, Capron F, Agut H, Gibert C, Chastre J.

Am J Respir Crit Care Med. 2007 May 1;175(9):935-42. Epub 2007 Jan 18.

PMID:
17234903
41.

[Herpes simplex virus vaccines: perspectives].

Deback C, Huraux JM.

Rev Med Interne. 2007 Jan;28(1):16-21. Epub 2006 Oct 12. Review. French.

PMID:
17095125
42.

Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.

Thi TN, Deback C, Malet I, Bonnafous P, Ait-Arkoub Z, Agut H.

Antiviral Res. 2006 Mar;69(3):152-7. Epub 2005 Dec 19.

PMID:
16388859

Supplemental Content

Loading ...
Support Center